KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Current Deferred Revenue (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Current Deferred Revenue for 13 consecutive years, with $1.7 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 21.31% to $1.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 21.31% year-over-year, with the annual reading at $1.7 million for FY2025, 21.31% down from the prior year.
  • Current Deferred Revenue hit $1.7 million in Q4 2025 for ClearPoint Neuro, down from $1.7 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $3.2 million in Q4 2023 to a low of $368000.0 in Q2 2021.
  • Historically, Current Deferred Revenue has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
  • Biggest five-year swings in Current Deferred Revenue: tumbled 42.71% in 2021 and later soared 136.78% in 2023.
  • Year by year, Current Deferred Revenue stood at $678000.0 in 2021, then surged by 114.9% to $1.5 million in 2022, then skyrocketed by 116.47% to $3.2 million in 2023, then crashed by 32.75% to $2.1 million in 2024, then dropped by 21.31% to $1.7 million in 2025.
  • Business Quant data shows Current Deferred Revenue for CLPT at $1.7 million in Q4 2025, $1.7 million in Q3 2025, and $1.4 million in Q2 2025.